Navigation Links
PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach
Date:7/28/2009

rucell's adenovirus-based program and the novel Ad35/Ad26 approach. The prime-boost regimen may be a critical next step in malaria vaccine development and, if successful, could move us toward our goal of having an 80 percent efficacious vaccine in use by 2025," said MVI Director, Dr. Christian Loucq.

Crucell is developing a recombinant malaria vaccine, Ad35-CS, based on the company's AdVac technology and PER.C6 manufacturing platform. The vaccine candidate is made by inserting the CSP gene from the P. falciparum malaria parasite into adenoviral vectors, which act as a 'vehicle' for vaccination delivery. This prime vaccine candidate is currently being tested in a Phase 1 study in partnership with the National Institute of Allergy and Infectious Diseases. This new collaboration will make it possible to clinically develop the Ad26 boost component of the vaccine and allow Crucell to further strengthen and expedite its malaria development program.

Carter Diggs at the USAID MVDP said, "We are pleased to support this adenovirus approach, which could play a vital role in malaria vaccine development."


'/>"/>

Contact: Preeti Singh
psingh@burnesscommunications.com
301-652-1558 x5722
Burness Communications
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Counterfeit antimalarial drug discovered in Ghana
2. New global subsidy for malaria medicines must ensure quality of care
3. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
4. Global Fund Increases AIDS, Tuberculosis and Malaria Prevention and Treatment Measures by 30-50% Over One Year
5. Marathon and Partners Announce Dramatic Results of Malaria Control Project on Bioko Island in Equatorial Guinea
6. Deploying the Power of Music to Save Lives West Africas Most Beloved Singer Raises His Voice to End Malaria
7. House Subcommittee Markup Leaves Global Fund to Fight AIDS, TB, and Malaria in Crisis
8. Washington, DC Community Leaders Commit to Send 10,000 Anti-Malarial Bed Nets to Refugees in Africa
9. Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment
10. Simple blood test proves powerful ally in the fight against malaria
11. UN Foundation to Help Protect More than a Million Refugees from Malaria in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015 Tel-Aviv – March ... prescription eyewear, announced the closing of $12.5 million in ... of the Viola Group. The funding will further GlassesUSA's ... leading player in the growing global market of online ... in 2009 by CEO Daniel Rothman, COO Eldad Rothman, ...
(Date:3/30/2015)... March 30, 2015 Recently, 10 Best ... Water Awards, with the top three winners being Fiji water, ... the company’s website, along with other informative information about water. ... water, spring water, mineral water and sparkling water are among ... of the top exotic water brands highlighted on the ...
(Date:3/30/2015)... Dr. Daniel Shapiro, one of the t op plastic ... Channel 12 News about the benefits of his latest procedure ... facelifts developed by Dr. Shapiro. , Over the past six ... Surgery and Skin Klinic worked closely with 12 News reporter ... The story detailed the experience and results of one of ...
(Date:3/30/2015)... March 30, 2015 Valerie Harper, the ... sitcoms “Rhoda” and “The Mary Tyler Moore Show,” will ... honoring oncology nurses, CURETM magazine announced today. Harper, who ... the Oncology Nursing Society’s 40th Annual Congress on April ... important role oncology nurses play in the lives of ...
(Date:3/30/2015)... 30, 2015 Slidezilla, an app from ... slideshow app that innovates the fun and simplicity of ... create animated photo slideshows and then instantly share them ... , "We wanted to create a slideshow app where ... have many fun options to personalize them. You can ...
Breaking Medicine News(10 mins):Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3
... ... sunscreen provides broad spectrum protection for skin from the sun,s harmful rays. , ... (PRWEB) June 30, 2010 ... is introducing a non-chemical natural sunscreen armed with unparalleled protection, barely-there feel, ...
... on recently-enacted health care reform legislation, the Patient Protection ... the American College of Physicians (ACP). An Internist,s ... by ACP,s Division of Governmental Affairs and Public Policy, ... health care reform legislation. "This 91-page document features ...
... Planet Symposium is on the innovative SMOS mission, which recently ... first observations due to be released in early July. ... in November to gather data on moisture in the surface ... oceans. SMOS will improve our understanding of the water cycle ...
... There ... given the large number of over-the-counter (OTC) pediatric product recalls as well as the dangerous ... ... filled with bumps, boos, strains and sprains. And with more children participating in rough ...
... ... platform for both Men and Women to ask their questions and give their answers. It seems ... offers a daily updated blog, with the ability to let users send their articles to be ... ...
... ... Channel® continue to beat expectations , , ... (PRWEB) June 30, 2010 -- Healing HealthCare Systems (HHS) based ... growth and consistent demand for its industry-leading product, The C.A.R.E. Channel , evidence-based relaxation ...
Cached Medicine News:Health News:As Summer Heats Up, Glacier Creme Debuts the Ultimate in Natural Sunscreen: 'Naked Protection' with Zinc Oxide 2Health News:Resource guide for internists released by ACP 2Health News:SMOS shines at symposium 2Health News:Topricin Junior: The Safe New Choice for Children's Pain Relief 2Health News:Topricin Junior: The Safe New Choice for Children's Pain Relief 3Health News:Get All Your Questions About Women and Relationships Solved Online At WomanAdvice.com 2Health News:Get All Your Questions About Women and Relationships Solved Online At WomanAdvice.com 3Health News:High Customer Retention and Continual Product Demand Drive Steady Growth for Innovative Healthcare Company 2
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 /PRNewswire/ ... announced that Tom Cannell has joined ... for global commercialization of Contrave® /Mysimba™ (naltrexone HCl ... all aspects of Orexigen,s global commercial strategy, assuming ... After successfully leading Orexigen,s commercial effort through the ...
(Date:3/30/2015)... March 30, 2015  New York College of Health ... Intellectual Properties portfolio with U.S. Patent #8,996,098 donated by ... patent represents a surgical instrument that allows surgeons to ... it were in the traditional format of a slide ... medical databases during surgery, thus providing the surgeon real ...
(Date:3/30/2015)... Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) ... to the position of Executive Vice President & ... be responsible for all legal, compliance and intellectual property ... BioDelivery Sciences International, Inc., where he was Senior Vice ... management that led that company to over a six ...
Breaking Medicine Technology:Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3
... Mich., Oct. 11 Pioneer Surgical Technology, Inc., ... the company,s plan to establish a manufacturing and ... with the IDA (Ireland Development Authority) to evaluate ...  The new facility will support Pioneer,s continued growth ...
... Biotechnology Corporation (NasdaqCM: GNBT) ( www.generex.com ) today ... agreement to acquire a majority interest (51%) in ... Lenexa, Kansas, a nationwide Durable Medical Equipment and ... medications ( www.globalmeddirect.com ). Generex Interim ...
Cached Medicine Technology:Pioneer® Surgical Technology, Inc. Announces Plans to Establish Manufacturing and Distribution Facility in Ireland 2Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 2Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 3Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 4Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 5Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 6Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 7Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies 8